Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Capecitabine
Xeloda
Routinely available
SMC (193/05)
01/10/2005
Indication
Following surgery for Stage III (Dukes C stage) colon cancer
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available
Formulation
150mg, 500mg tablets
Comments
October 2005 - Added to the Additional List, for Specialist Use only.